Journal Information

Statistics

Letter to the Editor
Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors’ reply
A. Cortegiania,b,
Corresponding author
andrea.cortegiani@unipa.it

Corresponding author at: Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy.
, M. Ippolitoa, S. Einavc
a Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy
b Department of Anesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy
c Intensive Care Unit of the Shaare Zedek Medical Medical Centre, Hebrew University Faculty of Medicine, Jerusalem, Israel
Read
432
Times
was read the article
93
Total PDF
271
Total HTML
68
Total EPUB
Share statistics
Article information
ISSN: 25310437
Original language: English
The statistics are updated each day
Year/Month Html Pdf Epub Total
2021 January 65 32 9 106
2020 December 82 34 5 121
2020 November 124 27 54 205
Pulmonology

Subscribe to our newsletter

Are you a health professional able to prescribe or dispense drugs?

Cookies policy
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.